)
Edge6 Feb 2026
SharkNinja: Viral by Design
How SharkNinja built a repeatable growth engine, turning overlooked appliance categories into global brands through consumer insight and iteration.
Bio-Rad Laboratories
Bio-Rad Laboratories (BIO) investor relations material
Bio-Rad Laboratories Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary12 Feb, 2026
Executive summary
2025 delivered modest revenue growth of 0.7% year-over-year, with results within revised guidance but gross margin impacted by higher supply chain costs, execution issues, and one-time write-offs.
Diagnostics segment returned to growth, driven by quality controls, blood typing, and diabetes products, while Life Science saw strong QX700 ddPCR sales but was impacted by constrained academic and biotech funding.
Process Chromatography business grew over 20% in 2025 but is expected to be volatile due to customer concentration and regulatory changes.
Expanded Droplet Digital PCR leadership via Stilla Technologies acquisition and integration, with positive initial market adoption and new partnerships advancing oncology diagnostics.
Generated $532M in cash from operations and $375M in free cash flow for 2025; $296M deployed for share repurchases.
Financial highlights
Q4 2025 revenue was $693M, up 3.9% year-over-year; full-year revenue was $2.583B, up 0.7%.
Q4 2025 non-GAAP gross margin: 52.5% (down from 53.9% in Q4 2024); full year non-GAAP gross margin: 53.3% (down from 55% in 2024).
Q4 2025 non-GAAP net income: $68M ($2.51 EPS), down from $81M ($2.90 EPS) in Q4 2024; full year non-GAAP net income: $271M ($9.92 EPS), down from $291M ($10.31 EPS) in 2024.
Q4 2025 operating loss: $119M (GAAP), including $173M in impairment charges; non-GAAP operating margin: 12% (down from 13.8%).
Free cash flow for 2025: $375M, up from $290M in 2024.
Outlook and guidance
2026 currency neutral revenue growth expected between 0.5%-1.5%; Q1 to be down low single-digit year-over-year, improving sequentially.
Life Science segment 2026 revenue growth guided at 0%-0.5%; core Life Science (ex-Process Chromatography) to grow nearly 4%, ddPCR mid-single-digit.
Process Chromatography projected to decline mid-teens in 2026, with long-term mid-single-digit growth expected.
Diagnostics segment 2026 revenue growth guided at 1%-2%; quality controls to grow mid-single-digit.
2026 non-GAAP gross margin projected at 54%-54.5%; operating margin at 12%-12.5%; free cash flow $375M-$395M.
What drives sustained gross margin improvement?
Process chrom: path to mid-single-digit growth?
Impact of R&D reprioritization on growth?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Bio-Rad Laboratories earnings date
Q1 202630 Apr, 2026
Bio-Rad Laboratories
Next Bio-Rad Laboratories earnings date
Q1 202630 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Bio-Rad Laboratories Inc develops, manufactures, and markets products for the life science research and clinical diagnostics markets. The company provides instruments, reagents, software, and services used in scientific discovery, biotechnology research, and medical diagnostics. Its products support laboratories, universities, hospitals, and research institutions worldwide. The company is headquartered in Hercules, California, and its shares are listed on the NYSE.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage